Health Care [ 5/12 ] | Health Care Technology [ 71/75 ]
NASDAQ | Common Stock
Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States.
It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery.
The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid.
Profusa, Inc. is based in Berkeley, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 19, 25 | -0.70 Decreased by -4.65 K% | - |
| Aug 22, 25 | -0.42 Decreased by -449.02% | - |
| Jun 27, 25 | -0.48 Decreased by -252.42% | - |
| Dec 31, 24 | -1.29 Decreased by -3.39 K% | - |
| Sep 30, 24 | 0.02 Increased by +125.84% | - |
| Jun 30, 24 | -0.08 Decreased by -155.35% | - |
| Mar 31, 24 | -0.14 Decreased by -777.61% | - |
| Dec 31, 23 | 0.04 Increased by +96.00% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 0.00 Decreased by -100.00% | -22.19 M Decreased by -788.75% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -8.20 M Decreased by -1.96 K% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -2.72 M Decreased by -13.88% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -7.59 M Decreased by -3.31 K% | Decreased by N/A% - |
| Sep 30, 24 | 75.00 K - | -2.50 M - | Decreased by -3.33 K% - |
| Jun 30, 24 | 0.00 - | -397.49 K - | Decreased by N/A% - |
| Mar 31, 24 | 0.00 - | -2.38 M - | Decreased by N/A% - |
| Dec 31, 23 | N/A - | 235.97 K - | - - |